Article
Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
Annals of the New York Academy of Sciences - 1 Nov 2007
Smith Roy G, Sun Yuxiang, Jiang Hong, Albarran-Zeckler Rosie, Timchenko Nikolai
Abstract excerpt
Administration of an orally active agonist (MK-0677) of the growth hormone secretagogue receptor (GHS-R1a) to elderly subjects restored the amplitude of endogenous episodic growth hormone (GH) release to that of young adults. Functional benefits include increased lean mass and bone density and modest improvements in strength. In old mice, a similar agonist partially restored function to the thymus and reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
